Please assess the completion status of the following clinical trial:

Trial Title: Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Ankle brachial index of \<0.9 in at least one leg~* History of intermittent claudication (unilateral or bilateral)~* A stable medication regimen for at least 6 months~Exclusion Criteria:~* Limiting coronary artery disease~* Renal failure (serum creatinine \> 0.20 mmol/L)~* Current treatment or treatment within the previous 6 months with ACE inhibitors or angiotensin II receptor antagonists

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).